Intranasal delivery of low-dose anti-CD124 antibody enhances treatment of chronic rhinosinusitis with nasal polyps.
Wu J, Jones N, Chao PH, Chan V, Hohenwarter L, Wu A, Bergamo M, Rodríguez-Rodríguez C, Saatchi K, Liang A, Häfeli UO, Tan Z, Hedtrich S, Andrew LJ, Li SD.
Wu J, et al. Among authors: chao ph.
Biomaterials. 2024 Jul;308:122567. doi: 10.1016/j.biomaterials.2024.122567. Epub 2024 Apr 6.
Biomaterials. 2024.
PMID: 38603825